Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.48
-0.14 (-2.49%)
At close: Aug 29, 2025, 4:00 PM
5.45
-0.03 (-0.55%)
After-hours: Aug 29, 2025, 6:29 PM EDT
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $426.72 million as of August 29, 2025. Its market cap has increased by 32.41% in one year.
Market Cap
426.72M
Enterprise Value
181.66M
1-Year Change
32.41%
Ranking
Category
Stock Price
$5.48
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $426.72M, a decrease of -94.16%. That is a compound annual growth rate of -31.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 426.72M | 167.00% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |